On September 15, a total of 3,849 A-shares were purchased with financing capital, and 241 shares were purchased for more than 100 million yuan. Among them, Cambrian, Zhongji Xuchuang, and China Jushi Finance ranked in the top three, receiving purchases of 1,789 billion yuan, 1,729 billion yuan, and 1.6 billion yuan respectively. Judging from the share of financing purchases in the total transaction amount for the day, 2 individual stocks accounted for more than 30% of the financing purchase amount. Among them, Haohai Biotech, Tianma Technology, and Jinshi Resources Finance ranked in the top three for the share of turnover, with 36.74%, 30.67%, and 29.45% respectively. Judging from the net purchase amount of financing, 11 individual stocks received a net purchase of over 100 million yuan. Among them, Cambrian, Changchuan, and Ningde Era Finance ranked in the top three, receiving net purchases of 1,032 million yuan, 272 million yuan, and 229 million yuan respectively.

On September 15, a total of 3,849 A-shares were purchased with financing capital, and 241 shares were purchased for more than 100 million yuan. Among them, Cambrian, Zhongji Xuchuang, and China Jushi Finance ranked in the top three, receiving purchases of 1,789 billion yuan, 1,729 billion yuan, and 1.6 billion yuan respectively. Judging from the share of financing purchases in the total transaction amount for the day, 2 individual stocks accounted for more than 30% of the financing purchase amount. Among them, Haohai Biotech, Tianma Technology, and Jinshi Resources Finance ranked in the top three for the share of turnover, with 36.74%, 30.67%, and 29.45% respectively. Judging from the net purchase amount of financing, 11 individual stocks received a net purchase of over 100 million yuan. Among them, Cambrian, Changchuan, and Ningde Era Finance ranked in the top three, receiving net purchases of 1,032 million yuan, 272 million yuan, and 229 million yuan respectively.